Vietnam · Delayed Price · Currency is VND HNX:MED Statistics
Total Valuation
HNX:MED has a market cap or net worth of VND 253.16 billion. The enterprise value is 255.98 billion.
| Market Cap | 253.16B |
| Enterprise Value | 255.98B |
Important Dates
The next estimated earnings date is Friday, April 17, 2026.
| Earnings Date | Apr 17, 2026 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
HNX:MED has 12.41 million shares outstanding.
| Current Share Class | 12.41M |
| Shares Outstanding | 12.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 37.15% |
| Owned by Institutions (%) | n/a |
| Float | 7.80M |
Valuation Ratios
The trailing PE ratio is 15.99.
| PE Ratio | 15.99 |
| Forward PE | n/a |
| PS Ratio | 0.69 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.65, with an EV/FCF ratio of -16.90.
| EV / Earnings | 16.17 |
| EV / Sales | 0.70 |
| EV / EBITDA | 8.65 |
| EV / EBIT | 11.41 |
| EV / FCF | -16.90 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.63 |
| Quick Ratio | 0.56 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.15 |
| Debt / FCF | -2.24 |
| Interest Coverage | 9.68 |
Financial Efficiency
Return on equity (ROE) is 4.78% and return on invested capital (ROIC) is 5.06%.
| Return on Equity (ROE) | 4.78% |
| Return on Assets (ROA) | 2.92% |
| Return on Invested Capital (ROIC) | 5.06% |
| Return on Capital Employed (ROCE) | 6.77% |
| Weighted Average Cost of Capital (WACC) | 4.29% |
| Revenue Per Employee | 1.18B |
| Profits Per Employee | 51.08M |
| Employee Count | 310 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 3.11 |
Taxes
In the past 12 months, HNX:MED has paid 4.83 billion in taxes.
| Income Tax | 4.83B |
| Effective Tax Rate | 23.36% |
Stock Price Statistics
The stock price has decreased by -23.02% in the last 52 weeks. The beta is -0.01, so HNX:MED's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -23.02% |
| 50-Day Moving Average | 24,554.00 |
| 200-Day Moving Average | 24,543.50 |
| Relative Strength Index (RSI) | 35.61 |
| Average Volume (20 Days) | 2,733 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HNX:MED had revenue of VND 366.83 billion and earned 15.83 billion in profits. Earnings per share was 1,275.86.
| Revenue | 366.83B |
| Gross Profit | 85.79B |
| Operating Income | 22.43B |
| Pretax Income | 20.66B |
| Net Income | 15.83B |
| EBITDA | 29.59B |
| EBIT | 22.43B |
| Earnings Per Share (EPS) | 1,275.86 |
Balance Sheet
The company has 31.10 billion in cash and 33.91 billion in debt, with a net cash position of -2.81 billion or -226.65 per share.
| Cash & Cash Equivalents | 31.10B |
| Total Debt | 33.91B |
| Net Cash | -2.81B |
| Net Cash Per Share | -226.65 |
| Equity (Book Value) | 331.31B |
| Book Value Per Share | 26,697.14 |
| Working Capital | 78.96B |
Cash Flow
In the last 12 months, operating cash flow was -5.38 billion and capital expenditures -9.77 billion, giving a free cash flow of -15.14 billion.
| Operating Cash Flow | -5.38B |
| Capital Expenditures | -9.77B |
| Depreciation & Amortization | 7.17B |
| Net Borrowing | 6.13B |
| Free Cash Flow | -15.14B |
| FCF Per Share | -1,220.28 |
Margins
Gross margin is 23.39%, with operating and profit margins of 6.11% and 4.32%.
| Gross Margin | 23.39% |
| Operating Margin | 6.11% |
| Pretax Margin | 5.63% |
| Profit Margin | 4.32% |
| EBITDA Margin | 8.07% |
| EBIT Margin | 6.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1,200.00, which amounts to a dividend yield of 5.88%.
| Dividend Per Share | 1,200.00 |
| Dividend Yield | 5.88% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 94.72% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.88% |
| Earnings Yield | 6.25% |
| FCF Yield | -5.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HNX:MED has an Altman Z-Score of 2.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.9 |
| Piotroski F-Score | 4 |